We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

35 hedge funds and large institutions have $1.72M invested in NKGen Biotech, Inc. Warrants in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

13% more funds holding

Funds holding: 31 → 35 (+4)

41% less capital invested

Capital invested by funds: $2.94M → $1.72M (-$1.22M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
35
Holders Change
+4
Holders Change %
+12.9%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
1
Closed
2
Calls
$13K
Puts
–
Net Calls
+$13K
Net Calls Change
-$17K

Top Buyers

Rank Fund Capital Flow
1
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$10.4K
2
PI
PEAK6 Investments
Illinois
+$8.74K
3
MF
Magnetar Financial
Illinois
+$6.38K
4
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
+$3.96K
5
CS
Clear Street
New York
+$127

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$11K
2
FLC
Fifth Lane Capital
Texas
-$911
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.17M – – –
HCM
2
Highbridge Capital Management
New York
$76K – – –
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$47K – – –
AA
4
AQR Arbitrage
Connecticut
$34K – – –
PC
5
Periscope Capital
Ontario, Canada
$31K – – –
DCM
6
Difesa Capital Management
New York
$29K – – –
KC
7
Kepos Capital
New York
$27K – – –
6CM
8
683 Capital Management
New York
$26K – – –
FTCM
9
Fir Tree Capital Management
New York
$26K – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
10
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$26K – – –
KL
11
KIM LLC
Kansas
$24K +$36.4K +92,040 New
Balyasny Asset Management
12
Balyasny Asset Management
Illinois
$21K – – –
PSAMP
13
P. Schoenfeld Asset Management (PSAM)
New York
$21K – – –
TCA
14
Taconic Capital Advisors
New York
$18K – – –
PAMP
15
Polar Asset Management Partners
Ontario, Canada
$16K – – –
FBCM
16
Fort Baker Capital Management
California
$15K – – –
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$13K – – –
SCM
18
Shaolin Capital Management
Florida
$13K – – –
AIMCA
19
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$10K – – –
RCM
20
Rivernorth Capital Management
Florida
$10K – – –
JG
21
Jefferies Group
New York
$9.1K – – –
ACM
22
Atalaya Capital Management
New York
$8K – – –
CH
23
CVI Holdings
Delaware
$8K – – –
Parallax Volatility Advisers
24
Parallax Volatility Advisers
California
$7K +$10.4K +26,329 New
PI
25
PEAK6 Investments
Illinois
$5.1K +$8.74K +22,078 New
1
2

NKGNW Hedge Fund Activity: Q2 2022 in Review

35 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q2 2022, worth a combined $1.72M — down 41% from $2.94M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NKGNW positions and 2 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Parallax Volatility Advisers, opening a new position worth an estimated $10.4K. The largest seller was Bank of America, exiting entirely with an estimated $11K sold.

  • 35 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q2 2022, up from 31 in Q1 2022.
  • Funds reported $1.72M of NKGen Biotech, Inc. Warrants stock for Q2 2022, down 41% quarter-over-quarter.
  • 6 funds opened new NKGen Biotech, Inc. Warrants positions in Q2 2022 and 2 closed out, a net change of +4 holders.
  • The largest NKGen Biotech, Inc. Warrants buyer in Q2 2022 was Parallax Volatility Advisers, an estimated $10.4K added.
  • The largest NKGen Biotech, Inc. Warrants seller in Q2 2022 was Bank of America, an estimated $11K sold.

Based on aggregated 13F filings for Q2 2022.